Dysregulation of lipid metabolism has been under intense scrutiny in the pathogenesis of AD ever since the ε4 allele of APOE, a major lipoprotein in the brain, is identified as the strongest risk factor for AD (Kim et al., 2009). This evidence concerns the gene APOE and Alzheimer disease.